MyAverix Finance
NS · Pharmaceuticals
Cohance Lifesciences Ltd (COHANCE)
Pharmaceuticals & Biotechnology
Cohance Lifesciences Ltd (COHANCE) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $174.87B, P/E ratio is 76.44, net margin is 21.0%, dividend yield is 0.22%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for COHANCE
Cohance Lifesciences Ltd (COHANCE) — FAQ
What is Cohance Lifesciences Ltd's market cap?
Cohance Lifesciences Ltd (COHANCE) has a reported market cap of $174.87B (data as of 2026-07-10).
What is COHANCE's P/E ratio?
The price-to-earnings (P/E) ratio for Cohance Lifesciences Ltd (COHANCE) is 76.44 (data as of 2026-07-10).
Does Cohance Lifesciences Ltd pay a dividend?
Cohance Lifesciences Ltd (COHANCE) shows a reported dividend yield of 0.22%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Cohance Lifesciences Ltd in?
Cohance Lifesciences Ltd (COHANCE) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is COHANCE listed on?
COHANCE is listed on NS.
What is Cohance Lifesciences Ltd's net margin?
Cohance Lifesciences Ltd (COHANCE) reports a net margin of 21.0% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.